These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
112 related items for PubMed ID: 15153030
1. Iron-catalyzed cross-coupling reactions. A scalable synthesis of the immunosuppressive agent FTY720. Seidel G, Laurich D, Fürstner A. J Org Chem; 2004 May 28; 69(11):3950-2. PubMed ID: 15153030 [Abstract] [Full Text] [Related]
7. Iron(III)-catalyzed four-component coupling reaction of 1,3-dicarbonyl compounds, amines, aldehydes, and nitroalkanes: a simple and direct synthesis of functionalized pyrroles. Maiti S, Biswas S, Jana U. J Org Chem; 2010 Mar 05; 75(5):1674-83. PubMed ID: 20131775 [Abstract] [Full Text] [Related]
8. FTY720 (fingolimod) for relapsing multiple sclerosis. Horga A, Montalban X. Expert Rev Neurother; 2008 May 05; 8(5):699-714. PubMed ID: 18457527 [Abstract] [Full Text] [Related]
9. Synthesis of a key intermediate for the preparation of FTY720 analogs. Hamada M, Adachi K, Hikawa H, Yokoyama Y. Chem Pharm Bull (Tokyo); 2012 May 05; 60(11):1395-8. PubMed ID: 23124563 [Abstract] [Full Text] [Related]
12. Synthesis and biological evaluation of 2,2-disubstituted 2-aminoethanols: analogues of FTY720. Kiuchi M, Adachi K, Kohara T, Teshima K, Masubuchi Y, Mishina T, Fujita T. Bioorg Med Chem Lett; 1998 Jan 06; 8(1):101-6. PubMed ID: 9925439 [Abstract] [Full Text] [Related]
13. Phosphorylation by sphingosine kinase 2 is essential for in vivo potency of FTY720 analogues. Högenauer K, Billich A, Pally C, Streiff M, Wagner T, Welzenbach K, Nussbaumer P. ChemMedChem; 2008 Jul 06; 3(7):1027-9. PubMed ID: 18383466 [No Abstract] [Full Text] [Related]
16. The sphingosine-1-phosphate analogue FTY720 reduces atherosclerosis in apolipoprotein E-deficient mice. Keul P, Tölle M, Lucke S, von Wnuck Lipinski K, Heusch G, Schuchardt M, van der Giet M, Levkau B. Arterioscler Thromb Vasc Biol; 2007 Mar 06; 27(3):607-13. PubMed ID: 17158351 [Abstract] [Full Text] [Related]
17. Selective iron-catalyzed cross-coupling reactions of grignard reagents with enol triflates, acid chlorides, and dichloroarenes. Scheiper B, Bonnekessel M, Krause H, Fürstner A. J Org Chem; 2004 May 28; 69(11):3943-9. PubMed ID: 15153029 [Abstract] [Full Text] [Related]
18. Immunosuppressive activity of FTY720, sphingosine 1-phosphate receptor agonist: II. Effect of FTY720 and FTY720-phosphate on host-versus-graft and graft-versus-host reaction in mice. Kataoka H, Ohtsuki M, Shimano K, Mochizuki S, Oshita K, Murata M, Sugahara K, Sato N, Hoshino Y, Chiba K. Transplant Proc; 2005 May 28; 37(1):107-9. PubMed ID: 15808562 [No Abstract] [Full Text] [Related]
19. Antibody against a novel, myriocin (ISP-I)-based immunosuppressant, FTY720. Fujita T, Matsumoto N, Uchida S, Kohno T, Shimizu T, Hirose R, Yanada K, Kurio W, Watabe K. Bioorg Med Chem Lett; 2000 Feb 21; 10(4):337-9. PubMed ID: 10714494 [Abstract] [Full Text] [Related]
20. Iron-catalyzed cross-coupling of imidoyl chlorides with Grignard reagents. Ottesen LK, Ek F, Olsson R. Org Lett; 2006 Apr 27; 8(9):1771-3. PubMed ID: 16623547 [Abstract] [Full Text] [Related] Page: [Next] [New Search]